KRAS (but not BRAF) mutations in ovarian serous borderline tumor are associated with recurrent low-grade serous carcinoma

BRAF and KRAS mutations in ovarian serous borderline tumors (OSBTs) and ovarian low-grade serous carcinomas (LGSCs) have been previously described. However, whether those OSBTs would progress to LGSCs or those LGSCs were developed from OSBT precursors in previous studies is unknown. Therefore, we as...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Tsang, Yvonne T., Deavers, Michael T., Sun, Charlotte C., Kwan, Suet-Yan, Kuo, Eric, Malpica, Anais, Mok, Samuel C., Gershenson, David M., Wong, Kwong-Kwok
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4095747/
https://ncbi.nlm.nih.gov/pubmed/24549645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.4252
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi